Stanley Chang
Director Ejecutivo en MEDIGEN BIOTECHNOLOGY CORP. .
Cargos activos de Stanley Chang
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
TBG DIAGNOSTICS LIMITED | Director/Miembro de la Junta | - | - |
MEDIGEN BIOTECHNOLOGY CORP. | Director Ejecutivo | 09/06/2003 | - |
Presidente | 09/06/2003 | - | |
MEDIGEN VACCINE BIOLOGICS CORPORATION | Presidente | 12/12/2012 | - |
Director Ejecutivo | 23/12/2014 | 17/11/2016 | |
WINSTON MEDICAL SUPPLY CO., LTD. | Presidente | 07/02/2014 | - |
TBG Biotechnology, Inc. | Director/Miembro de la Junta | - | - |
UMO International Co., Ltd. | Director/Miembro de la Junta | - | - |
TBG, Inc. (Taiwan)
TBG, Inc. (Taiwan) Financial ConglomeratesFinance TBG, Inc. operates as an investment holding company. The company is headquartered in Taipei, Taiwan. | Director/Miembro de la Junta | - | - |
Historial de carrera de Stanley Chang
Antiguos cargos conocidos de Stanley Chang.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Ameribankers Corp. | Presidente | - | 01/01/2000 |
Development Center for Biotechnology
Development Center for Biotechnology Medical/Nursing ServicesHealth Services The Development Center for Biotechnology of Taiwan is a nonprofit organization co-sponsored by government grants and private donations. It focuses on biotechnology and pharmaceutical industry. The company was founded in 1984 and is headquartered in Taipei, Taiwan. | Director/Miembro de la Junta | 11/07/2011 | - |
░░░ ░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formación de Stanley Chang.
University College London | Doctorate Degree |
National Taiwan University College of Medicine | Undergraduate Degree |
Estadísticas
Internacional
Taiwán | 10 |
Australia | 2 |
Reino Unido | 2 |
Operativa
Director/Board Member | 6 |
Chairman | 3 |
Chief Executive Officer | 2 |
Sectorial
Health Technology | 6 |
Consumer Services | 4 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
MEDIGEN BIOTECHNOLOGY CORP. | Health Technology |
WINSTON MEDICAL SUPPLY CO., LTD. | Health Technology |
MEDIGEN VACCINE BIOLOGICS CORPORATION | Health Technology |
Empresas privadas | 7 |
---|---|
TBG Diagnostics Ltd.
TBG Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology TBG Diagnostics Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It operates through the InVitro Diagnostics segment, which involves in the research of biological drugs and the retail and wholesale of veterinary drugs. The company was founded on September 26, 1989 and is headquartered in Melbourne, Australia. | Health Technology |
TBG, Inc. (Taiwan)
TBG, Inc. (Taiwan) Financial ConglomeratesFinance TBG, Inc. operates as an investment holding company. The company is headquartered in Taipei, Taiwan. | Finance |
Development Center for Biotechnology
Development Center for Biotechnology Medical/Nursing ServicesHealth Services The Development Center for Biotechnology of Taiwan is a nonprofit organization co-sponsored by government grants and private donations. It focuses on biotechnology and pharmaceutical industry. The company was founded in 1984 and is headquartered in Taipei, Taiwan. | Health Services |
Ameribankers Corp. | |
Medigreen Biotechnology Corp.
Medigreen Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Medigreen Biotechnology Corporation, founded on April 10th, 2002, is focusing on the development of botanical new drugs and is established by domestic and overseas outstanding enterprises and entrepreneurs, in accordance with the government's promotion policy, to develop the Chinese Traditional Medicine industry. The major stockholders of Medigreen include Medigen Biotechnology Corp., SunTen Phytotech Co., Ltd. and YFY Biotech Management Company, etc. Since the foundation, based on the mission of 'contribution to the human health' and on the main principle of the immunologic system, Medigreen has been worked on the R & D of new botanical drugs on 'cancer adjuvant', 'anti-ulcer' and 'respiratory tract diseases'. Medigreen develops diverse functional products and ingredients on the base of the Traditional Chinese Medicine theory, the concept of 'medicine and food from the same source', and the efficacy examination of biotechnology followed the new drug development process to contribute to the human health and to guarantee the persistent progress of the enterprise during the new drug development. | Health Technology |
TBG Biotechnology, Inc. | |
UMO International Co., Ltd. |
- Bolsa de valores
- Insiders
- Stanley Chang
- Experiencia